First, given the deleterious role of upregulated KIM1 in AKI, and the beneficial effects of upregulation/activation of YY1 on AKI (Fig. 3), our study supports further investigation into the development of YY1 agonists. The gene discussed is HAVCR1; the disease is acute kidney injury.